Benedito Antônio Lopes da Fonseca

Author

Also Known As

B A L Fonseca, B. A. L. da Fonseca, B.A.L Fonseca, B.A.L. Da Fonseca, B.A.L. Fonseca, B.A.L. da Fonseca, BERNARDO FONSECA, Benedito Antonio Lopes da Fonseca, Benedito A Fonseca, Benedito A L Fonseca

214

Publications

Citations

H-Index

118

Concepts

All Affiliations

Universidade de São Paulo Universidade de Ribeirão Preto Clinics Hospital of Ribeirão Preto Universidade Brasil Instituto Adolfo Lutz

About

Benedito Antônio Lopes da Fonseca is an author at Universidade de São Paulo specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	42	2.1K
2	Public Health	8	8	285
3	Natural Sciences	2	2	102
4	Allergy	2	2	23
5	Biochemistry	1	1	78

Benedito Antônio Lopes da Fonseca

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy Dimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca, Clinical Immunology Complement SystemDifferential Biological EfficacyCovid-19 PandemicImmunologySevere Covid-19	2020	256
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, The Lancet ThrombosisHematologyPatient SafetyRivaroxaban VersusPost-discharge Thromboprophylaxis	2021	245
Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease Gustavo Pompermaier Garlet, Walter Martins, Benedito Antônio Lopes da Fonseca, Journal Of Clinical Periodontology	2004	223
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries Abdul Rouf Banday, Megan L. Stanifer, Oscar Flórez-Vargas, Nature Genetics	2022	132
Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis Steven Pincus, Peter W. Mason, Eiji Konishi, Virology VaccinationPathogenesisImmunologyViral PathogenesisVirology	1992	126
Evaluation of Cardiac Involvement During Dengue Viral Infection Carlos Henrique Miranda, Marcos de Carvalho Borges, Alessandra Kimie Matsuno, Clinical Infectious Diseases	2013	116
First Complete Genome Sequence of Zika Virus ( <i>Flaviviridae</i> , <i>Flavivirus</i> ) from an Autochthonous Transmission in Brazil Mariana Sequetin Cunha, Danillo Lucas Alves Espósito, Iray Maria Rocco, Genome Announcements GeneticsSão Paulo StateGenomicsZika VirusAutochthonous Transmission	2016	113
Endemic paracoccidioidomycosis: relationship between clinical presentation and patients’ demographic features Fernando Bellissimo‐Rodrigues, Valdes Roberto Bóllela, Benedito Antônio Lopes da Fonseca, Medical Mycology Parasitic DiseaseDiagnostic MycologyPcm CasesFungal PathogenClinical Epidemiology	2012	112
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus Eiji Konishi, Steven Pincus, Benedito Antônio Lopes da Fonseca, Virology VaccinationVaccinologyVaccine DevelopmentMedicineVaccine Target	1991	110
Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice Benedito Antônio Lopes da Fonseca, Steven Pincus, Robert E. Shope, Vaccine	1994	98

Page 1